AstraZeneca gets OK for expanded Crestor useFederal regulators have granted AstraZeneca approval to market its cholesterol pill Crestor as a preventive measure against heart attack and stroke in patients with healthy cholesterol levels.
FDA Approves New Indication for CrestorOn Feb. 8 the U.S. Food and Drug Administration approved the cholesterol-lowering medication Crestor (rosuvastatin) for some patients who are at increased risk of heart disease but have not been diagnosed with it. The new indication is for reducing the likelihood of a heart attack or stroke or the need for a procedure to treat blocked or narrowed arteries in patients who have never been told ...
AstraZeneca gets OK for expanded Crestor useFederal regulators have granted AstraZeneca approval to market its cholesterol pill Crestor as a preventive measure against heart attack and stroke in patients with healthy cholesterol levels. The Food and Drug Administration decision will allow the company... Food and Drug Administration - AstraZeneca - Stroke - Heart disease - Health
Business briefs for Feb. 9The Food and Drug Administration decision will allow the company to promote Crestor to millions of U.S. patients who traditionally have not been candidates for cholesterol-lowering drugs. London-based AstraZeneca studied the new use in a much-heralded 2008 study, showing Crestor reduced heart attack, stroke and other problems by 44 percent in patients with normal cholesterol and slight heart ...
Women: Heed your heartMany women are shocked to learn that heart disease is the No. 1 killer for both women and men in the